A placebo-controlled trial of the immune modulator, lentinan, in HIV-positive patients: a phase I/II trial.

Murray Gordon(San Francisco General Hospital), Yoko Kaneko(Keio University), R. W. M. Wong, Teresa Greco, Mario Guralnik, Toshihide Mimura(Saitama Medical University), Bernard Bihari, Robert W. Gorter, Eric Goosby(Global Brain Health Institute), V Rudinicki

PubMed

January 1, 1998

Cited by 57

Related Papers

NAK is an IκB kinase-activating kinase

|Nature|2000|374

HIV seroconversion in intravenous drug users in San Francisco, 1985–1990

|AIDS|1994|179

Matrix Metalloproteinase Gene Activation Resulting from Disordred Epigenetic Mechanisms in Rheumatoid Arthritis

|International Journal of Molecular Sciences|2017|111

U.S. Public Health Service Task Force Recommendations for the Use of Antiretroviral Drugs in Pregnant Women Infected with HIV-1 for Maternal Health and for Reducing Perinatal HIV-1 Transmission in the United States

|Unknown|2000|104

Aberrant right subclavian artery in fetuses with Down syndrome: a systematic review and meta-analysis

|Ultrasound in Obstetrics and Gynecology|2015|100